Guriqbal S. Basi, Ph.D. Senior Vice President, Chief Scientific Officer…. c/o Sarepta Therapeutics, Inc. Cambridge, MA 02142 Dear Dr. Basi:Sarepta Therapeutics, Inc. • November 1st, 2017 • Pharmaceutical preparations • Massachusetts
We are pleased to confirm our agreement relating to your continued employment with Sarepta Therapeutics, Inc. (the “Company”) pursuant to the terms and conditions as set forth in this letter agreement (this “letter agreement”). Defined terms that are used but not defined herein shall have the meanings given to such terms as shown on Annex A. All payments and benefits payable pursuant to this letter agreement will be subject to applicable withholding taxes.
CONSULTING AGREEMENTConsulting Agreement • November 1st, 2017 • Sarepta Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS CONSULTING AGREEMENT (this “Agreement”), dated as of August 17, 2017 (the “Effective Date”), is entered into by and between by and between Sarepta Therapeutics, Inc., a Delaware corporation (the “Company”), and Edward M. Kaye, M.D. (the “Consultant”).
